リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study.」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study.

UCHIDA Yasuki 90814723 0000-0002-1999-4709 TSUGAWA Takuya TANAKA-MIZUNO Sachiko 50453824 NOMA Kazuo AOKI Ken FUKUNAGA Kentaro 0000-0002-6261-0344 NAKAGAWA Hiroaki 70799478 0000-0003-3830-765X KINOSE Daisuke 50572418 YAMAGUCHI Masafumi OSAWA Makoto NAGAO Taishi 40402739 OGAWA Emiko 00378671 NAKANO Yasutaka 00362377 0000-0001-7516-8690 滋賀医科大学

2020.12.28

概要

The constraint values of dose-volume histogram (DVH) parameters for radiation pneumonitis (RP) prediction have not been uniform in previous studies. We compared the differences between conventional DVH parameters and DVH parameters with high attenuation volume (HAV) in CT imaging in both esophageal cancer and lung cancer patients to determine the most suitable DVH parameters in predicting RP onset. Seventy-seven and 72 patients who underwent radiation therapy for lung cancer and esophageal cancer, respectively, were retrospectively assessed. RP was valued according to the Common Terminology Criteria for Adverse Events. We quantified HAV with quantitative computed tomography analysis. We compared conventional DVH parameters and DVH parameters with HAV in both groups of patients. Then, the thresholds of DVH parameters that predicted symptomatic RP and the differences in threshold of DVH parameters between lung cancer and esophageal cancer patient groups were compared. The predictive performance of DVH parameters for symptomatic RP was compared using the area under the receiver operating characteristic curve. Mean lung dose, HAV30% (the proportion of the lung with HAV receiving ≥30 Gy), and HAV20% were the top three parameters in lung cancer, while HAV10%, HAV5%, and V10 (the percentage of lung volume receiving 10 Gy or more) were the top three in esophageal cancer. By comparing the differences in the threshold for parameters predicting RP between the two cancers, we saw that HAV30% retained the same value in both cancers. DVH parameters with HAV showed narrow differences in the threshold between the two cancer patient groups compared to conventional DVH parameters. DVH parameters with HAV may have higher commonality than conventional DVH parameters in both patient groups tested.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999; 45: 323–329. https://doi.org/10.1016/s0360-3016(99)00183-2 PMID: 10487552

2. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 2003; 55: 110–115. https://doi.org/10.1016/s0360-3016(02)03807-5 PMID: 12504042

3. Ramella S, Trodella L, Mineo TC, Pompeo E, Stimato G, Gaudino D, et al. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys. 2010; 76: 110–115. https://doi. org/10.1016/j.ijrobp.2009.01.036 PMID: 19619955

4. Schneider BJ, Daly ME, Kennedy EB, Stiles BM. Stereotactic Body Radiotherapy for Early-Stage NonSmall-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline Summary. J Oncol Pract. 2018; 14: 180–186. https://doi.org/10.1200/JOP.2017.028894 PMID: 29257717

5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (Non-Small Cell Lung Cancer). Available online: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (accessed 21 December 2019).

6. Clinical Appropriateness Guidelines:Radiation Oncology Brachytherapy, intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatment guidelines [Available from: https://www.aimspecialtyhealth.com/PDF/Guidelines/2018/Jan01/ AIM_Guidelines_RadiationOncology.pdf.

7. Stahel R, Thatcher N, Fruh M, Le Pechoux C, Postmus PE, Sorensen JB, et al. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. Ann Oncol. 2011; 22: 1973–1980. https://doi.org/10.1093/annonc/mdr313 PMID: 21727198

8. De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le Pechoux C, Price A, et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol. 2010; 28: 5301–5310. https://doi. org/10.1200/JCO.2010.30.3271 PMID: 21079134

9. Uchida Y, Tsugawa T, Tanaka-Mizuno S, Noma K, Aoki K, Shigemori W, et al. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis. Radiat Oncol. 2017; 12: 160. https://doi.org/10.1186/s13014-017-0891-z PMID: 28969651

10. Kim DK, Hersh CP, Washko GR, Hokanson JE, Lynch DA, Newell JD, et al. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respir Res. 2011; 12: 9. https://doi.org/10.1186/1465- 9921-12-9 PMID: 21232152

11. Common Terminology Criteria for Adverse Events v. 5.0, National Cancer Institute, National Institute of Health, Rockville. 2009. Available online: https://ctep.cancer.gov/protocolDevelopment/electronic_ applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf (accessed December 21, 2019)

12. Ihaka R., Gentleman R. R: a language for data analysis and graphics. J Comp Graph Stat. 1966; 5:299–314. https://doi.org/10.1080/10618600.1996.10474713

13. Liang J, Bi N, Wu S, Chen M, Lv C, Zhao L, et al. Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial. Ann Oncol. 2017; 28: 777–783. https://doi.org/10.1093/annonc/mdx009 PMID: 28137739

14. Sun JM, Ahn YC, Choi EK, Ahn MJ, Ahn JS, Lee SH, et al. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. Ann Oncol. 2013; 24: 2088–2092. https://doi.org/10.1093/annonc/mdt140 PMID: 23592701

15. Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, et al. PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol. 2016; 34: 953–962. https://doi.org/10.1200/JCO.2015.64.8824 PMID: 26811519

16. Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 377: 1919–1929. https://doi. org/10.1056/NEJMoa1709937 PMID: 28885881

17. Inoue T, Shiomi H, Oh RJ. Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis. J Radiat Res. 2015; 56: 727–734. https://doi.org/10.1093/jrr/rrv019 PMID: 25887042

18. Kimura T, Togami T, Takashima H, Nishiyama Y, Ohkawa M, Nagata Y. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema. Br J Radiol. 2012; 85: 135–141. https://doi.org/10.1259/bjr/32629867 PMID: 21385918

19. Sanuki N, Ono A, Komatsu E, Kamei N, Akamine S, Yamazaki T, et al. Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy. J Radiat Res. 2012; 53: 110–116. https://doi.org/10.1269/jrr.110142 PMID: 22302051

20. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol. 2003; 67: 275–283. https://doi.org/10. 1016/s0167-8140(03)00119-1 PMID: 12865175

21. Takeda A, Kunieda E, Ohashi T, Aoki Y, Oku Y, Enomoto T, et al. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy. Chest. 2012; 141: 858–866. https://doi. org/10.1378/chest.11-1193 PMID: 21885726

22. Wang J, Cao J, Yuan S, Ji W, Arenberg D, Dai J, et al. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys. 2013; 85: 798–804. https://doi.org/10.1016/j.ijrobp.2012.06.040 PMID: 22836048

23. Yamamoto T, Kadoya N, Sato Y, Matsushita H, Umezawa R, Kubozono M, et al. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images. Clin Lung Cancer. 2018; 19: e85–e90. https://doi.org/10.1016/j.cllc.2017.05. 022 PMID: 28655592

24. Saito T, Nakayama H, Yamada T, Shiraishi S, Tokuuye K. Is severe emphysema, as defined by quantitative CT measurement, a negative risk factor of radiation fibrosis? Br J Radiol. 2018; 91: 20170921. https://doi.org/10.1259/bjr.20170921 PMID: 29651875

25. Newman KB, Lynch DA, Newman LS, Ellegood D, Newell JD Jr. Quantitative computed tomography detects air trapping due to asthma. Chest. 1994; 106: 105–109. https://doi.org/10.1378/chest.106.1. 105 PMID: 8020254

26. Mets OM, van Hulst RA, Jacobs C, van Ginneken B, de Jong PA. Normal range of emphysema and air trapping on CT in young men. AJR Am J Roentgenol. 2012; 199: 336–340. https://doi.org/10.2214/ AJR.11.7808 PMID: 22826394

27. Schroeder JD, McKenzie AS, Zach JA, Wilson CG, Curran-Everett D, Stinson DS, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol. 2013; 201: W460–W470. https://doi.org/10.2214/AJR.12.10102 PMID: 23971478

28. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. Copd. 2010; 7: 32–43. https://doi.org/10.3109/ 15412550903499522 PMID: 20214461

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る